Real-Time EHR Write-Back Speech Biomarker Screening
Key Facts
- GIA screens for 46 conditions (24 live, 22 coming soon) using 2,500+ speech biomarkers.
- Screening results are available in approximately 60 seconds and are written directly back to the EHR.
- GIA integrates with major EHR systems including Epic, Cerner, PointClickCare, MatrixCare, and American HealthTech.
- GIA is 510(k) cleared and HIPAA compliant, ensuring patient data security and privacy.
- GIA speaks 92 languages, facilitating broader access to screening.
This article explains how real-time EHR write-back speech biomarker screening simplifies clinical documentation. GIA integrates with EHR systems like Epic and Cerner, eliminating dual documentation by automatically writing screening results back to the patient's chart in 60 seconds, saving time and reducing errors from manual data entry.
What Are the Challenges of Traditional Clinical Screening and EHR Documentation?
Traditional clinical screening methods are challenging due to manual processes that cause delays in diagnosis and treatment. Clinicians must manually enter screening data into the EHR system, creating a dual documentation burden that consumes time and increases error risks; for example, cognitive decline screening shows 70.8% accuracy and depression screening shows 81.6% accuracy. The manual nature of these processes can also lead to inconsistencies in data, making it difficult to track patient progress and make informed decisions. Conditions like mild cognitive impairment (MCI) affect an estimated 12 million Americans. GIA simplifies this process, ensuring accurate and timely documentation without adding to the administrative burden on clinical staff.
How Does Speech Biomarker Screening Work with EHR Integration?
Speech biomarker screening works with EHR integration by analyzing speech patterns to identify indicators of underlying health issues and automatically writing the results back to the patient's EHR. This eliminates manual data entry, saving clinicians time and reducing errors. GIA speaks 92 languages and can administer Activities of Daily Living (ADLs) and Instrumental Activities of Daily Living (IADLs) assessments, with results written back to the EHR. This provides a complete view of the patient's functional abilities, aiding in care planning and management.
The Operator's Guide to Multimodal Clinical AI
What administrators, DONs, and regional operators need to know before evaluating clinical AI platforms. Covers EHR integration, staffing impact, reimbursement codes, and deployment timelines.
What Are the Benefits of Real-Time EHR Write-Back for Clinical Processes?
Real-time EHR write-back for clinical processes saves clinicians time, reduces errors, and improves efficiency. Automating documentation allows clinicians to focus on patient care, ensures accurate recording of screening results, and facilitates quicker, informed decisions. GIA also facilitates better communication and collaboration among healthcare providers. For example, the GIA screening for Parkinson's disease has an AUC of 0.97, giving clinicians valuable information. Finally, this also helps facilities stay compliant with CMS F-Tag 605, as it pertains to behavioral health screenings.
Which EHR Systems Are Supported and How Is Implementation Handled?
GIA supports a wide range of EHR systems, including Epic, Cerner, PointClickCare, MatrixCare, and American HealthTech. The implementation process is straightforward, with support provided to ensure a smooth transition. Our team works closely with healthcare organizations to configure the system and train staff on its use. GIA is HIPAA compliant and 510(k) cleared, providing assurance of data security and regulatory compliance. A demo can show you how easily GIA integrates into your current EHR.
How Accurate Is Speech Biomarker Technology?
Speech biomarker technology accuracy is high, with screening algorithms rigorously tested and validated for reliable results. For example, screening demonstrates 81.6% accuracy for depression, 80.0% for PTSD, and 77.5% for anxiety. GIA is a screening tool and does not provide diagnoses; clinicians review results and make informed decisions. The speech analysis incorporates over 2,500 speech biomarkers. GIA uses Samsung Health Grade Galaxy devices with Samsung Knox for secure data collection and transmission.
What About Reimbursement and CPT Codes?
Clinical screening EHR integration can be supported by existing reimbursement structures using several CPT codes. These include CPT code 96127, which typically reimburses between $6 and $10, CPT code 96116, which reimburses between $94 and $131, and CPT code 99309, which reimburses around $100. These codes can be used to bill for the time and resources involved in administering and interpreting the screening results. The cost-effectiveness of GIA is further enhanced by the time savings and efficiency gains it provides. Contact us to explore the financial benefits of implementing GIA.
Conclusion
Real-time EHR write-back is here. By automating the documentation process and integrating directly with leading EHR systems, GIA saves clinicians valuable time, reduces the risk of errors, and improves the efficiency of clinical clinical processes. With accuracy rates up to 81.6% for depression and an AUC of 0.97 for Parkinson's, GIA provides valuable screening information to support clinical decision-making, after clinician review. It is a 510(k) cleared and HIPAA compliant platform that enhances patient care and simplifies administrative tasks. If you're looking to improve your clinical clinical processes and patient outcomes, we invite you to request a demo to see how GIA can benefit your organization. GIA speaks 92 languages and can be deployed across various healthcare settings.
Sources & References
- Centers for Medicare & Medicaid Services (CMS). Quality measures and star ratings. cms.gov
- Alzheimer’s Association. 2024 Alzheimer’s Disease Facts and Figures. alz.org/facts
- Scienza Health clinical validation: 12.3M longitudinal PAC/LTC patient records, 27B clinical events.
- U.S. Food & Drug Administration. 510(k) device clearance database. fda.gov
David Kaiser is the Founder and CEO of Scienza Health, where he leads the development of GIA®, a Digital Human® that screens for 46 cognitive and neurological conditions using 2,500+ speech biomarkers in under 5 minutes. The platform is 510(k) cleared, HIPAA compliant, and has been validated on 12.3M patient records and 27B clinical events.
Frequently Asked Questions
Does GIA Provide a Diagnosis?
No, GIA screens and does not provide diagnoses. It assists healthcare professionals in identifying potential health issues based on speech patterns. A human-in-the-loop approach is always maintained, with clinicians reviewing the screening results and making diagnoses based on their professional judgment, before results are added to the clinical record.
How Long Does a Screening Take?
A screening with GIA typically takes under 5 minutes to administer. The results are available in 60 seconds. The speed of the screening process allows healthcare professionals to screen more patients in a shorter amount of time, improving efficiency and throughput. GIA can be easily integrated into existing clinical processes, minimizing disruption and maximizing productivity.
Is GIA HIPAA Compliant?
Yes, GIA is HIPAA compliant. Our system is designed to protect sensitive patient information and comply with all applicable regulations. We use Samsung Health Grade Galaxy devices with Samsung Knox for secure data collection and transmission. Our commitment to HIPAA compliance ensures that healthcare providers can use GIA with confidence, knowing that their patients' privacy is protected.
The Clinical Signal
Hear the latest episode on clinical AI screening in post-acute care.